Becton, Dickinson and Co. | BDX - Net Income


Becton, Dickinson and Co. reported $377M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Abbott USD 928M 149M Jun/2026
Agilent USD 362M 23M Jun/2026
Align Technology USD 108.29M 4.48M Jun/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Baxter International USD 126M 141M Jun/2026
Becton, Dickinson and Co. USD 377M 688M Jun/2026
Bio-Rad Laboratories USD 371.4M 898.5M Jun/2026
Boston Scientific USD 907M 434M Jun/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Danaher USD 870M 159M Jun/2026
Dentsply International USD 37M 47M Jun/2026
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 241.9M 138.8M Jun/2026
Globus Medical USD 151.57M 27.27M Jun/2026
Insulet USD 95M 3.9M Jun/2026
Integra LifeSciences USD 4.48M 9.1M Jun/2026
Intuitive Surgical USD 818.1M 3.4M Jun/2026
J&J USD 5.53B 299M Jun/2026
Medtronic USD 1.24B 100M Mar/2026
Solventum Corp USD 92M 79M Jun/2026
Stryker USD 1.28B 531M Jun/2026
Tandem Diabetes Care USD -21.17M 775K Jun/2026
Teleflex USD 99.69M 107.85M Jun/2026
Terumo JPY 70.43B 44.06B Jun/2026
Thermo Fisher Scientific USD 1.74B 85M Jun/2026
Zimmer Biomet Holdings USD 198.3M 39.8M Jun/2026